Drug Type Small molecule drug |
Synonyms BAY 545, BAY545 |
Target |
Action antagonists |
Mechanism A2bR antagonists(Adenosine A2b receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Molecular FormulaC18H22F3N3O4S |
InChIKeyNTYVAKNEYLJAPT-UHFFFAOYSA-N |
CAS Registry1699717-32-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pulmonary Fibrosis | Discovery | Germany | - |





